LifeStance Health Group Inc (LFST) FinancialsLFSTLifeStance Health Group Inc

Evaluating the bottom line, LifeStance Health Group, Inc. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 7.29%, while the net margin is 5.42%. These profitability ratios, combined with a Return on Equity (ROE) of 3.43%, provide a clear picture of how effectively LFST converts its operational activities into shareholder value.

In the context of the broader market, LFST competes directly with industry leaders such as CON and OPCH. With a market capitalization of $4.65B, it holds a significant position in the sector. When comparing efficiency, LFST's gross margin of 100.00% stands against CON's 28.41% and OPCH's 17.32%. Such benchmarking helps identify whether LifeStance Health Group, Inc. is trading at a premium or discount relative to its financial performance.

LifeStance has shown consistent revenue growth, with Q2 2026 revenue at $435.35 million and net income increasing to $23.61 million, reflecting a positive trend in profitability.